Christopher J Hale (Christopher Hale)

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 2

Top Topics

Long Non Coding Rna

Computed Tomography

Top Venues

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Rebecca Mazahreh, Marsha L Mason, John J Gosink, Devra J Olson, Robert Thurman, Christopher J Hale, Lori Westendorf, Thomas A Pires, Christopher I Leiske, Markus Carlson, Liem T Nguyen, Julia H Cochran, Nicole M Okeley, Roma Yumul, Steven Jin, Ivan J Stone, Disha Sahetya, Albina Nesterova, Sean Allred, Kelly M Hensley, Rachael Hu, Robert T Lawrence, Timothy S Lewis, Sharsti Sandall
SGN-CD228A is an investigational CD228-directed antibody-drug conjugate with potent antitumor activity across a wide spectrum of preclinical solid tumor models. Molecular cancer therapeutics (2023)
Robert P Lyon, Mechthild Jonas, Christopher Frantz, Esther S Trueblood, Roma Yumul, Lori Westendorf, Christopher J Hale, Jackie L Stilwell, Narayana Yeddula, Katie M Snead, Vineet Kumar, Gabriela I Patilea-Vrana, Kerry Klussman, Maureen C Ryan
SGN-B6A: A New Vedotin Antibody-Drug Conjugate Directed to Integrin Beta-6 for Multiple Carcinoma Indications. Molecular cancer therapeutics (2023)